Skip to content

Evaluation study of visceral fat and inflammatory markers by intake of banana

Evaluation study of visceral fat and inflammatory markers by intake of banana - Evaluation study of visceral fat and inflammatory markers by intake of banana

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000045655
Enrollment
36
Registered
2021-10-04
Start date
2021-10-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adults

Interventions

Ingest 2 bananas (about 120g of edible portion) every day for 4 weeks by 20:00 at non-specified time. There are no restrictions on the usual meal time. Do not ingest bananas for 4 weeks. There are

Sponsors

Akasaka Family Clinic
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document 2.Healthy Japanese who are 21 years old or more and under 44 years old at the time of obtaining consent 3.Persons who have BMI of 24 or more at the time of obtaining consent

Exclusion criteria

Exclusion criteria: 1.Persons who are currently suffering from some kind of disease and are judged by the investigator to need treatment 2.Persons with severe anemia 3.Pregnant, lactating, pregnant 4.Persons who may cause allergic symptoms to the ingredients contained in the test food 5.Persons with alcoholism or other mental disorders 6.Persons who have a smoking habit, those who have quit smoking for less than 10 year 7. Persons who may change their lifestyle during the examination period (night shift, long trip, etc.) 8.Persons who may develop seasonal allergic symptoms such as pollinosis during the test period 9.Persons who plan to take new health foods and supplement foods during the examination period 10.Persons who have received hormone replacement therapy within the past 6 months 11.Persons who have been treated with hospitalization within the past 6 months 12.Persons who participate in other clinical studies or participated in the last 3 months or plan to participate in other clinical studies. 13.Persons who are judged by the investigator to be inappropriate for this study.

Design outcomes

Primary

MeasureTime frame
Changes in visceral fat area 4 weeks after the start of ingestion

Secondary

MeasureTime frame
Fasting blood index (total protein, albumin, total cholesterol, LDL cholesterol, HDL cholesterol, neutral fat, urea nitrogen, creatinine, uric acid, aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), serum insulin, glycoalbumin, sodium, potassium, chlorine, calcium, magnesium, inorganic phosphorus, serum iron, blood count, high-sensitivity CRP, interleukin 6, ferritin) Body composition (body weight, BMI, lean body mass) Blood pressure (systolic blood pressure, diastolic blood pressure)

Countries

Japan

Contacts

Public ContactYuki Asahina

Healthcare Systems Co., Ltd. Research and Development Department

asahina.yuki@hc-sys.jp03-6809-2722

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026